Position in AGEN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$102,051
New position
Shares Held
33,350
first reported quarter
Ownership
0.074%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#33
of 103 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Claro Advisors Inc. holds $2,341,182 across 7 Biotechnology names. AGEN ranks #6 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,445 | $717,774 | |
| 2 | INCY |
Incyte Corp
|
4,212 | $477,472 | |
| 3 | EXEL |
Exelixis, Inc.
|
8,164 | $444,203 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
502 | $313,017 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
3,407 | $266,665 | |
| 6 | AGEN |
Agenus Inc
This page
|
33,350 | $102,051 | |
| 7 | AUTL |
Autolus Therapeutics plc
|
12,500 | $20,000 |
All Filings in AGEN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $102,051 | 33,350 | Shares | Sole | 2026-07-30 | |
| No filing history on record for this holder in this stock. | ||||||